Equities researchers at StockNews.com assumed coverage on shares of Aspira Women's Health ( NYSE:AWH – Free Report ) in a research report issued on Saturday. The firm set a 'sell' rating on the stock. Aspira Women's Health Stock Performance Aspira Women's Health Company Profile ( Free Report ) Aspira Women's Health Inc, together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering.

https://www.dailypolitical.com/2023/07/08/aspira-womens-health-nyseawh-receives-new-coverage-from-analysts-at-stocknews-com.html

#dailypolitical